Safety and Efficacy of Orally Administered NUV001 Nutraceutical Supplement in Sickle Cell Disease Patients

NCT05791591 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DIETARY_SUPPLEMENT: NUV001 - IR
DIETARY_SUPPLEMENT: NUV001 - GR
DIETARY_SUPPLEMENT: Placebo

Sponsor

LGD

Collaborators

[object Object]